Multiplexed High Content Hepatotoxicity Assays using iPSC-Derived Hepatocytes
18 Sep 2012

Human hepatocytes derived from stem cells can greatly accelerate the development of new chemical entities and improve drug safety by offering more clinically relevant cell-based models than those presently available. Human induced pluripotent stem cell (iPSC) derived hepatocytes express appropriate hepatocyte markers and demonstrate intrinsic hepatocyte functions similar to primary cells. We demonstrate several models for assessing general and specific hepatotoxicity that are well-suited for automated screening environments.

Molecular Devices®



Show    per page
1 of 4 Page     1 2 3  ... Next 
Food Safety Webinar: New Ideas to Overcome Current Challenges 24 Dec 2013Read
Microbial Genome Analysis in Lasergene Genomics Suite26 Jun 2013Read
Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications21 May 2013Read
CAP Releases First Evidence-Based Guideline for Validating Whole Slide Imaging (WSI)15 May 2013Read
Improve Efficiency of Variant Screening for Biological Drugs2 May 2013Read
DNASTAR - Ion Torrent Webinar 3 Apr 2013Read
Assembling and Analyzing Illumina Data in Lasergene Genomics Suite12 Mar 2013Read
Sanger Sequence Assembly and Analysis in Lasergene Core Suite13 Feb 2013Read
Genome Assembly and Gap Closure in Lasergene Genomics Suite 30 Jan 2013Read
Automated TruSeq RNA Sample Preparation from FFPE tissue21 Dec 2012Read

Buying guides

Write a Review

Join 200,000 Scientists Online

Become a member for FREE for access to:

  • 250,000 full product and supplier listings
  • 10,000 user reviews and comments
  • Daily news and videos
  • 2,500 application notes and videos
  • 2,000 of the best jobs in Science

Don't miss out!

Join The Community Today